08.00 Registration

09.00-12.15 Radionuclide production and radiochemistry
Chairs: Piero Salvadori & Olof Solin

09.00-9.30 Large scale production of
radionuclides for PET − Bill Alvord, US
09.30-10.00 Copper radionuclides for PET −
Miguel Avila-Rodriguez, Canada
10.00-10.30 An Industry perspective on future
of PET radiopharmaceuticals − Antony Gee, UK

11.00-11.30 After thirty years of target and radiochemistry developments, where are we? Where are we headed? − Tom Ruth, Canada
11.30-12.00 Asymmetric synthesis of PET
radiopharmaceuticals − Raisa Krasikova,
Russia
12.00-12.15 An 86Y-labeled mirror-image oligonucleotide: influence of Y-DOTA isomers on the biodistribution in rats − J Schlesinger, Germany

11.00-12.30 Technologist Session
Chairs: Kate Pedersen & Helena Luotolinna-Lybeck

11.00-11.30 Preparation of the patient prior to a
PET study − Marko Seppänen, Finland
11.30-11.50 Clinical PET Study - Radiographers
point of view − Heidi Betlehem, Finland
11.50-12.30 QA in Radiation protection in a
PET/CT facility −Kate Pedersen, Denmark

08.30-10.00 From Preclinical to Clinical Imaging in PET
Chairs: Pat Zanzonico & Merja Haaparanta-Solin

08.30-09.00 Role of small animal PET for molecular imaging in pre-clinical studies − Cristina Nanni, Italy
09.00-09.30 Preclinical PET in development of new drugs − Raymond E. Gibson, US
09.30-09.45 Radio- or Fluorecent-labeling of Protein through the Sel-Tag and its Application in Medical Imaging − Qing Cheng, Sweden
09.45-10.00 Paraquat Uptake in Adult and Fetal Macaque Brains in vivo: A PET Study − R Bartlett, US

10.00-10.30 Coffee and posters

10.30-12.00 Oncology
Chairs: Seppo Pyrhönen & Heikki Minn

10.30-11.00 PET/CT assessment of treatment response in Oncology − Sigrid Stroobats, Belgium
11.00-11.30 PET-based treatment planning in radiotherapy: a new standard? − Vincent Gregoire, Belgium
11.30-11.45 [18F]EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer − Gaber Komar, Finland
11.45-12.00 Incorporating hypoxia information from PET into treatment planning − Iuliana Toma-Dasu

09.30-11.50 Software Development session


09.30-9.50 Definitions for PET data classes in object oriented C# library - Harri Merisaari, Finland
Break
10.30-10.50 Vinci 3 and experience with multi-platform development - Stefan Vollmar, Germany
10.50-11.10 Workflow histories and image data with validation - Stefan Vollmar, Germany
11.10-11.30 Automated classification of dementia patterns in FDG-PET - Stewart Young, Germany
11.30-11.50 CarimasTurku: Analysis package for PET heart study - Chunlei Han, Finland

13.00-14.45 Cardiology
Chairs: Jaakko Hartiala & Juhani Airaksinen

13.00-13.30 New molecular imaging targets in cardiology − Frank Bengel, US
13.30-14.00 Hybrid imaging - revolution in cardiac imaging − Juhani Knuuti, Finland
14.00-14.15 Hybrid PET/CT imaging in the detection of coronary atherosclerosis with assessment of functionally significant stenoses − Esa Joutsiniemi, Finland
14.15-14.45 Clinical cardiac imaging – where are we going? − Marcelo Di Carli, US

14.45-15.30 Coffee and posters

15.30-17.00 Molecular Imaging in Endocrinology
Chairs: Cristina Nanni & Pirjo Nuutila

15.30-16.00 Imaging of neuroendocrine tumours – Klaas-Pieter Koopmans, The Netherlands
16.00-16.30 11C-DTBZ Positron Emission Tomography as a tool to measure pancreatic beta cell mass - Eric Liu, US
16.30-16.45 Trimetazidine improves heart function by reducing myocardial fatty acid oxidation in non-diabetic obese humans − Marco Bucci, Finland
16.45-17.00 [18F]Fluorodopa Positron Emission Tomography in Primary and Secondary Diagnosis of Neuroendocrine Tumors − Saila Kauhanen, Finland

Note: 13:00-17:00 HRRT Users Meeting

8.30-11.15 Neurotransmission
Chairs: Ulla Ruotsalainen & Juha Rinne

8.30-9.00 Imaging dopamine in cognition − David Brooks, UK
9.00-9.30 Amyloid imaging − Agneta Nordberg, Sweden

9.30-10.00 Coffee and posters

10.00-10.30 Advances in white matter imaging − Martha Shenton, US
10.30-11.00 How antipsychotics work - lessons from men, mice and molecules − Shitij Kapur, Canada
11.00-11.15 The effects of dopamine d2 receptor gene-related polymorphisms on human extrastriatal dopamine receptor availability in vivo − Mika Hirvonen, Finland